ebomi
Colour theme
Sign in
Insider · CIK 0001315082

RA Capital Healthcare Fund LP

CIK 0001315082 Name as filed on the most recent filing

Filed as RA Capital Healthcare Fund LP (210)· RA Capital Biotech Fund LP (22)

1,052 transaction lines · from 232 filings · filed 2006-12-29 to 2026-08-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-08-26 P, Open-market purchase Achillion Pharmaceuticals IncACHN 2 lines 1,012,743, acquired Open Form 4 filing 0001144204-15-002866
2013-08-22 P, Open-market purchase Achillion Pharmaceuticals IncACHN 356,164, acquired Open Form 4 filing 0001144204-15-002866
2013-08-21 S, Open-market sale Achillion Pharmaceuticals IncACHN 29,641, disposed Open Form 4 filing 0001144204-15-002866
2013-08-21 P, Open-market purchase Achillion Pharmaceuticals IncACHN 154,590, acquired Open Form 4 filing 0001144204-15-002866
2013-08-20 S, Open-market sale Achillion Pharmaceuticals IncACHN 68,307, disposed Open Form 4 filing 0001144204-15-002866
2013-08-20 P, Open-market purchase Achillion Pharmaceuticals IncACHN 259,844, acquired Open Form 4 filing 0001144204-15-002866
2013-08-09 P, Open-market purchase Achillion Pharmaceuticals IncACHN 485,100, acquired Open Form 4 filing 0001144204-15-002866
2013-08-05 S, Open-market sale Achillion Pharmaceuticals IncACHN 164,336, disposed Open Form 4 filing 0001144204-15-002866
2013-08-02 P, Open-market purchase Achillion Pharmaceuticals IncACHN 161,319, acquired Open Form 4 filing 0001144204-15-002866
2013-07-29 S, Open-market sale Achillion Pharmaceuticals IncACHN 23,479, disposed Open Form 4 filing 0001144204-15-002866
2013-07-29 P, Open-market purchase Achillion Pharmaceuticals IncACHN 2 lines 123,501, acquired Open Form 4 filing 0001144204-15-002866
2013-07-25 S, Open-market sale Achillion Pharmaceuticals IncACHN 2 lines 398,089, disposed Open Form 4 filing 0001144204-15-002866
2013-07-25 P, Open-market purchase Achillion Pharmaceuticals IncACHN 268,003, acquired Open Form 4 filing 0001144204-15-002866
2013-07-25 S, Open-market sale Sangamo Biosciences IncSGMO 5 lines 3,582,848, disposed Open Form 4 filing 0001144204-15-010744
2013-07-24 S, Open-market sale Achillion Pharmaceuticals IncACHN 57,040, disposed Open Form 4 filing 0001144204-15-002866
2013-07-23 S, Open-market sale Sangamo Biosciences IncSGMO 46,938, disposed Open Form 4 filing 0001144204-15-010744
2013-07-22 P, Open-market purchase Achillion Pharmaceuticals IncACHN 2 lines 455,837, acquired Open Form 4 filing 0001144204-15-002866
2013-07-22 S, Open-market sale Sangamo Biosciences IncSGMO 3 lines 1,065,610, disposed Open Form 4 filing 0001144204-15-010744
2013-07-19 S, Open-market sale Achillion Pharmaceuticals IncACHN 276,960, disposed Open Form 4 filing 0001144204-15-002866
2013-07-19 S, Open-market sale Sangamo Biosciences IncSGMO 4 lines 2,065,714, disposed Open Form 4 filing 0001144204-15-010744
2013-07-18 S, Open-market sale Sangamo Biosciences IncSGMO 741,498, disposed Open Form 4 filing 0001144204-15-010744
2013-07-17 P, Open-market purchase Achillion Pharmaceuticals IncACHN 272,387, acquired Open Form 4 filing 0001144204-15-002866
2013-07-17 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 493,401, disposed Open Form 4 filing 0001144204-15-010744
2013-07-17 P, Open-market purchase Sangamo Biosciences IncSGMO 187,895, acquired Open Form 4 filing 0001144204-15-010744
2013-04-29 P, Open-market purchase Derma Sciences, Inc.DSCI 44,973, acquired Open Form 4 filing 0001144204-13-025732
2010-02-26 S, Open-market sale Biospecifics Technologies CorpBSTC 288,300, disposed Open Form 4 filing 0001209191-10-012662
2010-02-23 S, Open-market sale Biospecifics Technologies CorpBSTC 29,487, disposed Open Form 4 filing 0001209191-10-011846
2010-02-22 S, Open-market sale Biospecifics Technologies CorpBSTC 618,000, disposed Open Form 4 filing 0001209191-10-011846
2010-02-17 S, Open-market sale Biospecifics Technologies CorpBSTC 1,452,500, disposed Open Form 4 filing 0001209191-10-010848
2010-02-03 S, Open-market sale Biospecifics Technologies CorpBSTC 3,825,590, disposed Open Form 4 filing 0001209191-10-007638
2009-04-28 P, Open-market purchase Biospecifics Technologies CorpBSTC 293,179, acquired Open Form 4 filing 0001209191-09-025859
2009-04-27 P, Open-market purchase Biospecifics Technologies CorpBSTC 1,940, acquired Open Form 4 filing 0001209191-09-025859
2009-04-24 P, Open-market purchase Biospecifics Technologies CorpBSTC 11,419, acquired Open Form 4 filing 0001209191-09-025859
2009-04-14 P, Open-market purchase Biospecifics Technologies CorpBSTC 16,650, acquired Open Form 4 filing 0001209191-09-022639
2009-04-13 P, Open-market purchase Biospecifics Technologies CorpBSTC 5,126, acquired Open Form 4 filing 0001209191-09-022639
2009-04-09 P, Open-market purchase Biospecifics Technologies CorpBSTC 121,961, acquired Open Form 4 filing 0001209191-09-021540

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. RA Capital Healthcare Fund LP, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001315082

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.